Ames Products
|
Product |
Art.No. |
|
|
Ames MPF PENTA I - 10 Sample Kit - 480 Measuring Points / Strain |
C10-512 |
|
|
10 vials semisolid TA98 |
||
|
10 vials semisolid TA100 |
||
|
10 vials semisolid TA1535 |
||
|
10 vials semisolid TA1537 |
||
|
10 vials semisolid E.coli uvrA and E.coli pKM101 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF PENTA I - 10 Sample Kit - S9 - Positive Controls |
||
|
same components as in C10-512, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C10-512-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C10-512-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF PENTA I - 1 Sample Starter Kit - 48 Measuring Points / Strain |
||
|
1 Vial semisolid TA98 |
||
|
1 Vial semisolid TA100 |
||
|
1 Vial semisolid TA1535 |
||
|
1 Vial semisolid TA1537 |
||
|
1 Vial semisolid E.coli uvrA and E.coli pKM101 |
||
|
1 Vial Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C01-512-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C01-512-S2-P |
|
|
positive controls |
|
|
|
Ames MPF 98/100/1535/1537 - 10 Sample Kit |
A10-410 |
|
|
480 Measuring Points / Strain |
||
|
10 vials semisolid TA98 |
||
|
10 vials semisolid TA100 |
||
|
10 vials semisolid TA1535 |
||
|
10 vials semisolid TA1537 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF 98/100/1535/1537 - 10 Sample Kit - S9 - Positive Controls |
||
|
same components as in A10-410, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A10-410-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A10-410-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 98/100/1535/1537 - 1 Sample Starter Kit |
||
|
48 Measuring Points / Strain |
||
|
1 Vial semisolid TA98 |
||
|
1 Vial semisolid TA100 |
||
|
1 Vial semisolid TA1535 |
||
|
1 Vial semisolid TA1537 |
||
|
1 Vial Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A01-410-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A01-410-S2-P |
|
|
Positive controls |
|
|
|
Ames II - 10 Sample Kit - 480 Measuring Points / Strain |
E10-213 |
|
|
10 vials liquid TA98 |
||
|
10 vials liquid TAMix |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive control, +/- S9 |
||
|
Ames II - 10 Sample Kit with Rat Liver S9 and Positive Controls |
||
|
same components as above (E10-213), plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
E10-213-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
E10-213-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 98/100 - 10 Sample Kit - 480 Measuring Points / Strain |
A10-210 |
|
|
10 vials semisolid TA98 |
||
|
10 vials semisolid TA100 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive control, +/- S9 |
||
|
Ames MPF 98/100 - 10 Sample Kit with Rat Liver S9 and Positive Controls |
||
|
same components as in A10-210, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A10-210-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A10-210-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 98/100 - 1 Sample Starter Kit - 48 Measuring Points / Strain |
||
|
1 Vial semisolid TA98 |
||
|
1 Vial semisolid TA100 |
||
|
1 Vial Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A01-210-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A01-210-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 98/100 Aqua - 5 Sample Kit - 240 Measuring Points / Strain |
J05-210 |
|
|
5 vials semisolid TA98 |
||
|
5 vials semisolid TA100 |
||
|
5 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 5 compounds, triplicates, 6 concentrations, negative and positive control, +/- S9 |
||
|
Ames MPF 98/100 Aqua - 5 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in J05-210, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
J05-210-S1-P |
|
|
Positive controls |
|
|
|
Ames MPF 98 - 10 Sample Kit - 480 Measuring Points |
A10-110 |
|
|
10 vials semisolid TA98 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF 98 - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in A10-110, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A10-110-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A10-110-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF98 - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid TA98 |
||
|
1 Vial Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A01-110-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/ß-Naphtoflavone induced |
A01-110-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 100 - 10 Sample Kit - 480 Measuring Points |
A10-111 |
|
|
10 vials semisolid TA100 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF 100 - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in A10-111, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A10-111-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A10-111-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 100 - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid TA100 |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A01-111-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A01-111-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 1535 - 10 Sample Kit - 480 Measuring Points |
A10-112 |
|
|
10 vials semisolid TA1535 |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF 1535 - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in A10-112, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A10-112-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A10-112-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 1535 - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid TA1535 |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A01-112-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A01-112-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 1537 - 10 Sample Kit - 480 Measuring Points |
A10-113 |
|
|
10 vials semisolid TA1537 |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF 1537 - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in A10-113, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A10-113-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A10-113-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF 1537 - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid TA1537 |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
A01-113-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
A01-113-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF E.coli uvrA - 10 Sample Kit - 480 Measuring Points |
C10-115 |
|
|
10 vials semisolid E.coli uvrA |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF E.coli uvrA - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in C10-115, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C10-115-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C10-115-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF E.coli uvrA - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid E.coli uvrA |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C01-115-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C01-115-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF E.coli pKM - 10 Sample Kit - 480 Measuring Points |
C10-116 |
|
|
10 vials semisolid E.coli pKM101 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF E.coli pKM - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in C10-116 plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C10-116-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C10-116-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF E.coli pKM - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid E.coli pKM101 |
||
|
1 Vial Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C01-116-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C01-116-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF E.coli Combo - 10 Sample Kit - 480 Measuring Points |
C10-117 |
|
|
10 vials semisolid E.coli uvrA |
||
|
10 vials semisolid E.coli pKM101 |
||
|
10 vials Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media and strains provided are sufficient to analyze at least 10 compounds, triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
Ames MPF E.coli Combo - 10 Sample Kit - Rat Liver S9 - Positive Controls |
||
|
same components as in C10-117, plus: |
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C10-117-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C10-117-S2-P |
|
|
Positive controls |
|
|
|
Ames MPF E.coli Combo - 1 Sample Starter Kit - 48 Measuring Points |
||
|
1 Vial semisolid E.coli uvrA |
||
|
1 Vial semisolid E.coli pKM101 |
||
|
1 Vial Ampicillin |
||
|
Growth -, Exposure - and Reversion Indicator Media |
||
|
All media, strains, positive controls and S9 provided in the kit are sufficient to analyze at least 1 compound, in triplicates, 6 concentrations, negative and positive controls, +/- S9 |
||
|
|
||
|
Lyophilized rat liver S9, Aroclor 1254 induced or |
C01-117-S1-P |
|
|
Lyophilized rat liver S9, Phenobarbital/β-Naphtoflavone induced |
C01-117-S2-P |
|
|
Positive controls |
|
|
|
Media, strains, rat liver S9, positive controls, accessories |
|
|
|
|
||
|
Product |
Art.No. |
|
|
|
||
|
Ames MPF / Ames II - Ready to use media (RT) |
|
|
|
Ames MPF / Ames II Growth Medium, 50 ml |
PMM-GM00 |
|
|
Ames MPF / Ames II Salmonella Exposure Medium, 50 ml |
PMM-EM02 |
|
|
Ames MPF / Ames II Salmonella Reversion Indicator Medium, 550 ml |
PMM-IM10 |
|
|
|
||
|
Ames MPF E.coli - Ready to use Media (RT) |
|
|
|
Ames Growth Medium, 50 ml |
PMM-GM00 |
|
|
Ames MPF E.coli Exposure Medium, 50 ml |
PME-EM22 |
|
|
Ames MPF E.coli Reversion Indicator Medium, 550 ml |
PME-IM31 |
|
|
|
||
|
Ames – Semisolid S. typhimurium Strains |
|
|
|
50 µl TA98 |
PSS-0110 |
|
|
50 µl TA100 |
PSS-0111 |
|
|
50 µl TA1535 |
PSS-0112 |
|
|
50 µl TA1537 |
PSS-0113 |
|
|
Shipping: room temperature (cool packs) / Storage: -70oC |
|
|
|
|
||
|
Ames – Liquid S. typhimurium Strains |
|
|
|
50 µl TA98 |
PLI-0110 |
|
|
50 µl TAMix |
PLI-0114 |
|
|
Shipping: dry ice / Storage: -70oC |
|
|
|
|
||
|
Ames - Semisolid E.coli Strains |
|
|
|
50 µl E.coli WP2 uvrA |
PSS-0115 |
|
|
50 µl E.coli WP2 pKM101 |
PSS-0116 |
|
| 50 µl E.coli WP2 uvrA(pKM101) | ||
|
Shipping: room temperature / Storage: -70oC |
|
|
|
|
||
|
Ampicillin (-20°C) |
PAM-0001 |
|
|
|
||
|
Rat liver S9 |
|
|
|
|
|
|
|
0,4 ml Aroclor induced Lyophilized microsomal rat liver S9 |
PRS-AC00 |
|
|
1 ml Aroclor induced Lyophilized microsomal rat liver S9 |
PRS-AC01 |
|
|
2 ml Aroclor induced Lyophilized microsomal rat liver S9 |
PRS-AC02 |
|
|
|
||
|
Rat liver S9 |
|
|
|
0,4 ml Phenobarbital/β-Naphtoflavone induced Lyophilized rat liver S9 |
PRS-PB00 |
|
|
1 ml Phenobarbital/β-Naphtoflavone induced Lyophilized rat liver S9 |
PRS-PB01 |
|
|
2 ml Phenobarbital/β-Naphtoflavone induced Lyophilized rat liver S9 |
PRS-PB02 |
|
|
|
||
|
Frozen, liquid microsomal rat liver S9 is available on request |
|
|
|
|
||
|
S9 Cofactor Kit |
PCO-0800 |
|
|
20 ml S9-Buffer-Salts, 0.9 ml S9-G-6-P, 3.5 ml S9-NADP |
|
|
| 1 kit is sufficient for all 1 sample kits; all 10 sample kits with 1 and 2 strains | ||
| 2 kits are needed for the 10 sample kit with 4 strains and PENTA I kit | ||
|
|
||
|
Positive Controls |
|
|
|
20 µg 2-NF: 2-Nitrofluorene |
PPC-NF00 |
|
|
100 µg 2-AA: 2-Aminoanthracene |
PPC-AA01 |
|
|
2 mg 2-AA: 2-Aminoanthracene |
PPC-AA02 |
|
|
50 µg 4-NQO: 4-Nitroquinoline-N-Oxide |
PPC-NQ02 |
|
|
2,5 mg N4-ACT: N4-Aminocytidine |
PPC-AC02 |
|
|
1000 µg 9-AAC: 9-Aminoacridine |
PPC-AR05 |
|
|
10 mg AF10: 2-Aminofluorene |
PPC-AF10 |
|
Druckversion 